A randomised comparison of a foot pump and low-molecular-weight heparin in the prevention of deep-vein thrombosis after total knee replacement

Journal of Bone and Joint Surgery - Series B

Volumn 84, Issue 3, 2002, Pages 344-350

  Warwick, D ^a   Harrison, J ^a   Whitehouse, S ^a   Mitchelmore, A ^a   Thornton, M ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOOT; HEMATEMESIS; HEMATOMA; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PHLEBOGRAPHY; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; PUMP; RANDOMIZED CONTROLLED TRIAL; SOFT TISSUE DEFECT; STATISTICAL ANALYSIS; TOTAL KNEE REPLACEMENT;

EID: 0036227473     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.84B3.12372     Document Type: Article

References (53)

1. The contrast between venographic and clinical endpoints in trials of thromboprophylaxis in hip replacement
2. Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty: A meta-analysis of randomised trials
3. Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty
4. Prevention of deep vein thrombosis after major knee surgery: A randomised, double blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo
5. Ardeparin (low molecular weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism: A randomised trial in patients undergoing knee surgery
6. A comparison of subcutaneous low-molecular weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation
7. The return of blood to the heart: Venous pumps in health and disease
8. Pneumatic calf compression, fibrinolysis and the prevention of deep venous thrombosis
9. A venous foot pump reduces thrombosis after total hip replacement
10. The A-V impulse system reduces deep vein thrombosis and swelling after hemiarthroplasty for hip fracture
11. The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty
12. Prophylaxis against deep-vein thrombosis in total hip replacement: Comparison of heparin and foot impulse pump
13. Comparison of the use of a foot pump with the use of low molecular weight heparin for the prevention of deep-vein thrombosis after total hip replacement: A prospective, randomised trial
14. Thromboembolic prophylaxis in total knee replacement: Evaluation of the A-V Impulse system
15. Prophylaxis against deep venous thrombosis after total knee arthroplasty: Pneumatic plantar compression and aspirin compared with aspirin alone
16. Prevention of deep vein thrombosis in knee arthroplasty: Preliminary results from a randomised controlled study of low molecular weight heparin vs foot pump compression
17. Prevention of deep-vein thrombosis after total knee replacement: Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump system
18. Trials to assess equivalence: The importance of rigorous methods
19. The incidence of deep vein thrombosis after cementless and cemented knee replacements
20. The incidence of fatal pulmonary embolism after knee replacement with no prophylactic anticoagulation
21. Incidence of fatal pulmonary embolism after 1390 knee arthroplasties without routine prophylactic anticoagulation, except in high risk cases
22. Clinical venous thromboembolism after total knee replacement
23. Postoperative surveillance for deep venous thrombosis with duplex ultrasonography after total knee arthroplasty
24. The significance of calf thrombi after total knee arthroplasty
25. Indications for the treatment of deep venous thrombosis following total knee replacement
26. Progression and regression of deep vein thrombosis after total knee arthroplasty
27. The clinical course of distal deep venous thrombosis after total hip and knee arthroplasty, as determined with duplex ultrasonography
28. Risk of deep venous thrombosis after hospital discharge in patients having undergone total hip replacement: Double blind randomised comparison of enoxaparin versus placebo
29. Low molecular weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
30. Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty: The Danish prolonged prophylaxis (DaPP) study
31. Prolonged thromboprophylaxis following hip replacement surgery: Results of a double blind, prospective, randomised placebo-controlled study with dalteparin (Fragmin)
32. Low molecular weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: A double-blind, randomized comparison
33. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement: A randomized, double-blind, placebo-controlled trial
34. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin
35. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty
36. A double blind multi centre clinical trial comparing long term enoxaparin and placebo treatments in the prevention of venous thromboembolic disease after hip and knee replacement surgery
37. Prolonged prophylaxis after joint replacement: Another step sideways?
38. Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery
39. Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression
40. Mechanical measures in the prophylaxis of postoperative thromboembolism in total knee arthroplasty
41. Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep-vein thrombosis after total knee arthroplasty
42. Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail?
43. Prevention of thromboembolic disease following total knee arthroplasty: Epidural versus general anaesthesia
44. Lower thrombosis risk with epidural blockade in knee arthroplasty
45. Effects of epidural anesthesia on the incidence of deep-venous thrombosis after total knee arthroplasty
46. Randomized trial of epidural versus general anesthesia: Outcomes after primary total knee replacement
47. Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquet
48. Thrombo-embolism coincident with tourniquet deflation during total knee arthroplasty
49. Effects of tourniquet use on blood loss and incidence of deep vein thrombosis in total knee arthroplasty
50. The tourniquet in total knee arthroplasty: A prospective, randomised study
51. Deep-vein thrombosis and continuous passive motion after total knee arthroplasty
52. The effect of the position of the limb on venous impulse foot pumps
53. Better reporting of randomised controlled trials: The CONSORT statement